Pharmacokinetics in serum and leukocyte exposures of oral azithromycin, 1,500 milligrams, given over a 3- or 5-day period in healthy subjects

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 1, 1999, Pages 163-165

  Amsden, Guy W ^a   Nafziger, Anne N ^a   Foulds, George ^b  

^a BASSETT RESEARCH INSTITUTE   (United States)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG HALF LIFE; FEMALE; HUMAN; HUMAN EXPERIMENT; LEUKOCYTE COUNT; MALE; MINIMUM INHIBITORY CONCENTRATION; NEUTROPHIL; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0032958771     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.1.163     Document Type: Article

References (18)

1. Amsden, G. W. 1996. Erythromycin, clarithromycin, and azithromycin: arc the differences real? Clin. Ther. 18:56-72.
2. Amsden, G. W., C. H. Ballow, and A. Forrest. 1997. Comparison of the plasma, urine and blister fluid pharmacokinetics of clarithromycin and azithromycin in normal subjects. Clin. Drug Invest. 13:152-161.
3. Baldwin, D. R., R. Wise, J. M. Andrews, J. P. Ashby, and D. Honeybourne. 1990. Azithromycin concentrations at the site of pulmonary infections. Eur. Respir. J. 3:886-890.
4. Ballow, C. H., and G. W. Amsden. 1992. Azithromycin: the first azalide antibiotic. Ann. Pharmacother. 26:1253-1261.
5. Ballow, C. H., G. W. Amsden, V. S. Highet, and A. Forrest. 1998. Pharmacokinetics of oral azithromycin in serum, urine, polymorphonuclear leukocytes and inflammatory vs. non-inflammatory skin blisters. Clin. Drug Invest. 15:159-167.
6. h. Cockcroft, D. W., and M. H. Gault. 1976. Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41.
7. Craig, W. A. 1997. Postantibiotic effects and the dosing of macrolides, azalides, and streptogramins p. 27-38. In S. H. Zinner, L. S. Young, J. F. Acar, and H. C. Neu (ed.). Expanding indications for the new macrolides, azalides, and streptogramins. Marcel Dekker, New York, N.Y.
8. Foulds, G., and R. B. Johnson. 1993. Selection of dose regimens of azithromycin. J. Antimicrob. Chemother. 31(Suppl. E):39-50.
9. Foulds, G., R. M. Shepard, and R. B. Johnson. 1990. The pharmacokinetics of azithromycin in human serum and tissues. J. Antimicrob. Chemother. 25(Suppl. A):73-82.
10. Gladue, R. P., L. M. Bright, R. E. Isaacson, and M. F. Newborg. 1989. In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection. Antimicrob. Agents Chemother. 3:277-282.
11. Gladue, R. P., and M. E. Snider. 1990. Intracellular accumulation of azithromycin by cultured human fibroblasts. Antimicrob. Agents Chemother. 34: 1056-1060.
12. Nibbering, P. H., T. P. L. Zomerdijk, A. J. Corsèl-Van Tilburg, and R. Van Furth. 1990. Mean cell volume of human blood leukocytes and resident and activated murine macrophages. J. Immunol. Methods 129:143-145.
13. Olsen, K. M., G. S. San Pedro, L. P. Gann, P. O. Gubbins, D. M. Halinski, and G. D. Campbell, Jr. 1996. Intrapulmonary pharmacokinetics of azithromycin in healthy volunteers given five oral doses. Antimicrob. Agents Chemother. 40:2852-2855.
14. Pfizer Inc. 1997. Product information. Zithromax. Pfizer Inc., Groton, Conn.
15. Shepard, R. M., and F. C. Falkner. 1990. Pharmacokinetics of azithromycin in rats and dogs. J. Antimicroh. Chemother. 25(Suppl. A):49-60.
16. Tanswell, P., and J. Koup. 1993. TopFit: a PC based pharmacokinetic/ pharmacodynamic data analysis program. Int. J. Clin. Pharmacol. Ther. Toxicol. 31:514-520.
17. Wildfeuer, A., H. Laufen, M. Leitold, and T. Zimmermann. 1993. Comparison of the pharmacokinetics of three-day and five-day regimens of azithromycin in plasma and urine. J. Antimicrob. Chemother. 31(Suppl. E):51-56.
18. Wildfeuer, A., H. Laufen, D. Müller-Wening, and O. Haferkamp. 1990. Interaction of azithromycin and human phagocyte cells. Arzneim.-Forsch. 39:755-758.